Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
GE HealthCare Technologies Inc.(GEHC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for GEHC
10/02/2026: GEHC (1-star) is currently NOT-A-BUY. Pass it for now.
GE HealthCare Technologies is a leading provider of medical imaging, ultrasound, and patient monitoring systems, operating as an independent company since its 2023 spin-off. The company's strengths lie in its massive global installed base and high-margin service revenue. Its primary investment story centers on the integration of AI to advance diagnostic precision and clinical efficiency. Key risks include intense competitive pricing, supply chain complexity, and sensitivity to hospital budget cycles. The stock may best suit investors seeking exposure to established healthcare infrastructure with moderate, stable growth prospects and a commitment to R&D, with dividend suitability currently in the early stages of development.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers moderate growth potential tied to clinical innovation rather than explosive top-line expansion. |
| Momentum investor | Strong fit while signal remains positive | Momentum investors may find value in recent performance trends provided the stock sustains a positive technical upturn. |
| Value investor | Strong fit | GEHC often presents an attractive valuation relative to high-growth tech, appealing to those seeking stable returns. |
| Dividend investor | Mixed fit | While a dividend is paid, it is relatively new and may not satisfy investors seeking long-standing, high-yield income histories. |
| Low-risk investor | Strong fit | The company's role as a fundamental provider of global healthcare infrastructure offers relatively defensive characteristics. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock is subject to broader market trends and shifts in hospital capital spending cycles. |
| Valuation risk | Medium | As an independent entity, the market's assessment of its long-term margin potential can cause price swings. |
| Competition risk (AI competition) | High | New entrants in AI-driven diagnostics could threaten traditional imaging hardware margins. |
| Business quality | Strong | The company possesses a massive global installed base which provides resilient, long-term service revenue. |
| Dividend income | Low / none | The dividend is recently established and may not be the primary focus for income-oriented investors yet. |
| Execution risk | Medium | Successfully integrating new AI software into legacy hardware systems requires precise execution. |
Price Behavior
Downtrend
The stock has experienced a sustained decline in price over recent periods.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -20.56% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/02/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 29.04B USD | Price to earnings Ratio 14.81 | 1Y Target Price 83.05 |
Price to earnings Ratio 14.81 | 1Y Target Price 83.05 | ||
Volume (30-day avg) 3.3M shares | Beta 0.82 | 52 Weeks Range 58.72 - 89.64 | Updated Date 10/02/2026 |
52 Weeks Range 58.72 - 89.64 | Updated Date 10/02/2026 | ||
Dividends yield (FY) 0.22% | Basic EPS (TTM) 4.34 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Imaging | CT, MRI, X-ray equipment and sales. | The backbone of the company, providing most hardware revenue. |
| Ultrasound | Ultrasound systems for various medical specialties. | A high-growth segment benefiting from portable tech trends. |
| Service | Maintenance, support, and software updates. | The most stable, recurring part of the business model. |
| Geography | North America, Europe, China, and RoW. | Revenue is well-diversified geographically, reducing reliance on any single market. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 14.81 | Forward PE 12.12 | Enterprise Value 38.31B | Price to Sales(TTM) 1.38 |
Enterprise Value 38.31B | Price to Sales(TTM) 1.38 | ||
Enterprise Value to Revenue 1.8 | Enterprise Value to EBITDA 10.37 | Shares Outstanding 451.69M | Shares Floating 450.20M |
Shares Outstanding 451.69M | Shares Floating 450.20M | ||
Percent Insiders 0.37 | Percent Institutions 94 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About GE HealthCare Technologies Inc.
Exchange NASDAQ | Headquarters Chicago, IL, United States | ||
IPO Launch date 2023-01-04 | President, CEO & Director Mr. Peter J. Arduini | ||
Sector Healthcare | Industry Medical Devices | Full time employees 54000 | Website https://www.gehealthcare.com |
Full time employees 54000 | Website https://www.gehealthcare.com | ||
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.